Saturday, July 11, 2026

Drug profile · INN

triptorelin

triptorelin (DECAPEPTYL) is a gonadotropin-releasing hormone receptor agonist. Associated with Ferring Pharmaceuticals.

TGA: approved
Patents linked 0
Pipeline programs 17
News articles 0
Drug details — triptorelin

Quick answer

triptorelin (DECAPEPTYL) is a gonadotropin-releasing hormone receptor agonist. Associated with Ferring Pharmaceuticals.

Key facts

INN triptorelin
Brand DECAPEPTYL
Mechanism Gonadotropin-releasing hormone receptor agonist

Mechanism of action

Gonadotropin-releasing hormone receptor agonist

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. 1414-ROG-GUCG Phase 3 · Ningbo Cancer Hospital · very high risk localized or locally advanced prostate cancer
  2. BAY 1841788, TRIPTORELIN Phase 3 · Ningbo Cancer Hospital · Patients with localised prostate cancer and high-risk featur
  3. CAAA617C12301 Phase 3 · Novartis India · PSMA-positive metastatic hormone-sensitive prostate cancer (
  4. D8535C00001 Phase 3 · AstraZeneca · ER+/HER2- Early Breast Cancer
  5. EORTC-2238-GUCG Phase 3 · Ningbo Cancer Hospital · Metastatic hormone naïve prostate cancer (mHNPC)
  6. MEDOPP545 Phase 3 · Stemline Therapeutics (United · patients with estrogen receptor-positive/human epidermal gro
  7. Testosterone Gel 1% for low ovarian reserve according t… Phase 3 · George Institute for · low ovarian reserve according to Bologna criteria and carrie
  8. Triptorelin for Injection Phase 3 · First People's Hospital · Ovarian Hyperstimulation Syndrome

Frequently asked questions

What is triptorelin?

triptorelin (DECAPEPTYL) is a gonadotropin-releasing hormone receptor agonist. Associated with Ferring Pharmaceuticals.

What is the brand name for triptorelin?

DECAPEPTYL is a marketed brand name for triptorelin. Check FDA Drugs@FDA for the current US label holder and prescribing information.